Non Invasive Blood Pressure
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Element BiosciencesCA - San Diego
2 programsNon Invasive Blood PressureN/A
Non-invasive blood pressureN/A
PhilipsNetherlands - Amsterdam
2 programsNon Invasive Blood PressureN/A1 trial
Non-invasive blood pressureN/A2 trials
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
PhilipsNon-invasive blood pressure
PhilipsNon Invasive Blood Pressure
PhilipsNon-invasive blood pressure
Clinical Trials (3)
Total enrollment: 273 patients across 3 trials
Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study
Start: Oct 2026Est. completion: Dec 202685 patients
N/ARecruiting
Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor
Start: Mar 2025Est. completion: Mar 202599 patients
N/ACompleted
Philips Non-Invasive Blood Pressure Validation Study
Start: Oct 2024Est. completion: Oct 202489 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 273 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.